drugset / Trial / NCT05602116
ASC - Autism Study
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The ASC - Autism Pilot Study is a single center randomized open dose titrating phase I clinical intervention pilot trial with the aim of investigating safety and treatment effect of an allogeneic adipose tissue derived mesenchymal stromal cell product (C2C\_ASC) in children with autism spectrum disorder (ASD) and gastrointestinal symptoms.
Timeline
- Start
- 2023-06-09
- Primary completion
- 2024-06-28
- Completion
- 2024-09-20